SPX3,693.23-64.76 -1.72%
DIA295.86-4.66 -1.55%
IXIC10,867.93-198.88 -1.80%

Why Amazon, Microsoft, Apple Shares Are Trading Lower, Here Are 50 Stocks Moving In Tuesday's Mid-Day Session

Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) jumped 186% to $47.69 as the stock started trading on a 1-for-30 reverse split basis.

Benzinga · 09/13/2022 12:32

Gainers

  • NeuroBo Pharmaceuticals, Inc. (NASDAQ:NRBO) jumped 186% to $47.69 as the stock started trading on a 1-for-30 reverse split basis.
  • Akero Therapeutics, Inc. (NASDAQ:AKRO) shares climbed 111% to $25.88 after the company's Phase 2b HARMONY study met its primary endpoint for both the 50mg and 28mg EFX dose groups.
  • Comera Life Sciences Holdings, Inc. (NASDAQ:CMRA) rose 47.4% to $2.83 after a late Monday Form 4 filing showed multiple insider purchases of the stock.
  • 89bio, Inc. (NASDAQ:ETNB) shares gained 32.4% to $6.62. Analysts reportedly said Akero's NASH data could be a positive for the company's Pegoza program in NASH.
  • VNET Group, Inc. (NASDAQ:VNET) surged 30.7% to $6.13 after the company announced the receipt of a preliminary non-binding proposal to acquire all of its shares and formation of a special committee to review the proposal.
  • Hycroft Mining Holding Corporation (NASDAQ:HYMC) gained 28% to $1.0199. The company earlier reported initial drill results from its 2022-2023 exploration program.
  • Aditxt, Inc. (NASDAQ:ADTX) gained 26% to $0.2188.
  • Aprea Therapeutics, Inc. (NASDAQ:APRE) jumped 26% to $1.00.
  • Planet Labs PBC (NYSE:PL) rose 15.1% to $6.24 after the company reported better-than-expected Q2 results and raised guidance.
  • Tyme Technologies, Inc. (NASDAQ:TYME) rose 14.7% to $0.2950 after gaining around 4% on Monday.
  • Fresh Track Therapeutics, Inc. (NASDAQ:FRTX) surged 14.7% to $2.42. Fresh Tracks Therapeutics initiated multiple ascending dose portion of Phase 1 study of DYRK1A inhibitor FRTX-02.
  • Motorsport Games Inc. (NASDAQ:MSGM) gained 13.7% to $0.8603. Motorsport Games, last month, reported worse-than-expected Q2 EPS results.
  • Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) rose 13.3% to $17.16. S&P Dow Jones Indices said Catalyst Pharmaceuticals will replace Mantech International Corp. in S&P Smallcap 600 on September 15.
  • Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) shares rose 13% to $0.8250 after the FDA granted Syros Pharmaceuticals Orphan Drug Designation for the treatment of pancreatic cancer.
  • Tyme Technologies, Inc. (NASDAQ:TYME) jumped 11.9% to $0.2880.
  • Aehr Test Systems (NASDAQ:AEHR) gained 11.4% to $15.70 after the company received a wafer level burn-in system order.
  • Celularity Inc. (NASDAQ:CELU) rose 11.3% to $2.6050.
  • iBio, Inc. (NYSE:IBIO) rose 10.6% to $0.2996 after declining over 4% on Monday.
  • Blue Star Foods Corp. (NASDAQ:BSFC) gained 10.3% to $1.17 as the company signed a one-year extension to its multi-year supply contract with Sysco Corp.
  • Yoshiharu Global Co. (NASDAQ:YOSH) rose 8.8% to $3.3214.
  • LSB Industries, Inc. (NYSE:LXU) gained 6.9% to $17.13. Piper Sandler initiated coverage on LSB Industries with an Overweight rating and announced a price target of $26.
  • Core & Main, Inc. (NYSE:CNM) rose 3.7% to $25.40 following upbeat Q2 results.


Losers

  • Cardiff Oncology, Inc. (NASDAQ:CRDF) fell 32% to $2.1799. Following a strategic review, Cardiff Oncology decided it will not independently fund any future clinical activities in metastatic castrate-resistant prostate cancer (mCRPC), citing clinical data and therapeutic landscape.
  • Rent the Runway, Inc. (NASDAQ:RENT) shares fell 31.5% to $3.3750 after the company reported issued Q3 guidance below estimates and announced a workforce reduction of 24% of corporate employees. Credit Suisse downgraded the stock from Outperform to Neutral and lowered the price target from $7 to $4.
  • Codiak BioSciences, Inc. (NASDAQ:CDAK) fell 29% to $1.1850 after the company priced 13.33 million share offering plus accompanying warrants at combined price of $1.50 per share plus warrant.
  • InMed Pharmaceuticals Inc. (NASDAQ:INM) fell 21.3% to $14.79. InMed Pharmaceuticals recently announced a $6 million private placement priced at $8.68 per share.
  • Tuesday Morning Corporation (NASDAQ:TUEM) dropped 21% to $0.1529. The company recently announced it has entered into an agreement to secure $32 million in convertible debt financing.
  • Benitec Biopharma Inc. (NASDAQ:BNTC) declined 19.3% to $0.5125 as the company reported pricing of $18 million underwritten public offering.
  • PolyPid Ltd. (NASDAQ:PYPD) fell 18.1% to $1.3992 after jumping 58% on Monday. The company earlier announced it will present Phase 2 D-PLEX₁₀₀ data at the European Society for Coloproctology Scientific Conference next week.
  • Nocera, Inc. (NASDAQ:NCRA) declined 17% to $2.10.
  • Rubius Therapeutics, Inc. (NASDAQ:RUBY) dropped 16% to $0.8990 after the company discontinued ongoing Phase 1 trials of RTX-240 and RTX-224 in advanced solid tumors.
  • Braze, Inc. (NASDAQ:BRZE) fell 15% to $37.00 after the company reported Q2 earnings results and issued Q3 2023 adjusted EPS guidance below estimates.
  • Relay Therapeutics, Inc. (NASDAQ:RLAY) shares fell 14.9% to $24.51. Relay Therapeutics priced 11.32 million share public offering of common stock at $26.50 per share.
  • Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) dropped 14.5% to $26.64.
  • WalkMe Ltd. (NASDAQ:WKME) declined 14.4% to $9.47. WalkMe announced the departure of Chief Financial Officer Andrew Casey.
  • AMTD Digital Inc. (NYSE:HKD) declined 13.8% to $50.20.
  • BridgeBio Pharma, Inc. (NASDAQ:BBIO) fell 14% to $10.64.
  • Pacific Biosciences of California, Inc. (NASDAQ:PACB) dipped 13.5% to $6.01.
  • Peloton Interactive, Inc. (NASDAQ:PTON) fell 13.5% to $9.55 after the company announced Executive Chair John Foley will step down, effective Sept. 12. Karen Boone has been elected Chairperson of the Board.
  • Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) slipped 13.4% to $13.93.
  • Carvana Co. (NYSE:CVNA) fell 12.4% to $37.02.
  • Soluna Holdings, Inc. (NASDAQ:SLNH) dropped 12% to $2.7690.
  • Wayfair Inc. (NYSE:W) fell 11.7% to $49.40.
  • Unity Software Inc. (NYSE:U) dropped 11.4% to $37.48 after Applovin announced it does not intend to submit another proposal to combine with the company and has withdrawn its Aug. 9 proposal.
  • Asana, Inc. (NYSE:ASAN) fell 10.3% to $25.75.
  • Upstart Holdings, Inc. (NASDAQ:UPST) dipped 9% to $25.47.
  • AppLovin Corporation (NASDAQ:APP) fell 6.1% to $26.76. Applovin announced it does not intend to submit another proposal to combine with Unity Software and has withdrawn its Aug. 9 proposal.
  • Amazon.com, Inc. (NASDAQ:AMZN) dipped 5.8% to $128.55 after August CPI data showed greater-than-expected US inflation.
  • Microsoft Corporation (NASDAQ:MSFT) fell 4.3% to $255.23 after August CPI data showed greater-than-expected US inflation.
  • Apple Inc. (NASDAQ:AAPL) fell 4.1% to $156.76 amid overall market weakness after August CPI readings showed inflation came in greater than expected.